Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Total Liabilities (2020 - 2025)

Historic Total Liabilities for Core Scientific (CORZ) over the last 6 years, with Q3 2025 value amounting to $3.4 billion.

  • Core Scientific's Total Liabilities rose 10735.49% to $3.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 billion, marking a year-over-year increase of 10735.49%. This contributed to the annual value of $2.4 billion for FY2024, which is 8478.35% up from last year.
  • As of Q3 2025, Core Scientific's Total Liabilities stood at $3.4 billion, which was up 10735.49% from $3.0 billion recorded in Q2 2025.
  • Core Scientific's 5-year Total Liabilities high stood at $3.4 billion for Q3 2025, and its period low was $29.8 million during Q1 2021.
  • Over the past 5 years, Core Scientific's median Total Liabilities value was $1.3 billion (recorded in 2023), while the average stood at $1.4 billion.
  • Per our database at Business Quant, Core Scientific's Total Liabilities surged by 26329440000.0% in 2021 and then crashed by 2661.81% in 2023.
  • Core Scientific's Total Liabilities (Quarter) stood at $1.1 billion in 2021, then increased by 15.56% to $1.2 billion in 2022, then grew by 7.56% to $1.3 billion in 2023, then surged by 84.78% to $2.4 billion in 2024, then skyrocketed by 41.54% to $3.4 billion in 2025.
  • Its last three reported values are $3.4 billion in Q3 2025, $3.0 billion for Q2 2025, and $1.8 billion during Q1 2025.